Skip to main content
. 2023 Dec 6;9(4):e003349. doi: 10.1136/rmdopen-2023-003349

Figure 3.

Figure 3

Meta-analyses summary. The values shown are mean differences in overall fatigue levels and their 95% CIs from the comparison of the identified pharmacological intervention versus placebo. A negative value indicates a reduction in fatigue levels. MD, mean difference; RA, rheumatoid arthritis; SpA, spondyloarthritis.